News und Analysen
![Eilt: Großinvestoren vor Einstieg in diesen Biotech Hot Stock - Massives Kaufsignal. Neuer 133% Biotech Hot Stock nach 3.296% mit BioNTech ($BNTX), 10.996% mit Pfizer ($PFE), 31.205% mit Amgen ($AMG) und 134.452% mit Biogen ($BIIB): https://www.irw-press.at/prcom/images/messages/2024/73280/AC_Vidac_170124.001.png](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBN2tOYkE9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--c20e7c27b57a33326714fc1e27bfac678f92c52e/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/AC_Vidac_170124.001.png?locale=de)
Eilt: Großinvestoren vor Einstieg in diesen Biotech Hot Stock - Massives Kaufsignal. Neuer 133% Biotech Hot Stock nach 3.296% mit BioNTech ($BNTX), 10.996% mit Pfizer ($PFE), 31.205% mit Amgen ($AMG) und 134.452% mit Biogen ($BIIB)
Eilt: Großinvestoren vor Einstieg in diesen Biotech Hot Stock - Massives Kaufsignal. 133% Biotech Aktientip nach 15.973%
17.01.24 08:02
London (www.aktiencheck.de, Anzeige)
![Eilt: Großinvestoren vor Einstieg in diesen Biotech Hot Stock - Massives Kaufsignal. Neuer 133% Biotech Hot Stock nach 3.296% mit BioNTech ($BNTX), 10.996% mit Pfizer ($PFE), 31.205% mit Amgen ($AMG) und 134.452% mit Biogen ($BIIB): https://www.irw-press.at/prcom/images/messages/2024/73280/AC_Vidac_170124.001.png](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBN2tOYkE9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--c20e7c27b57a33326714fc1e27bfac678f92c52e/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/AC_Vidac_170124.001.png?locale=de)
Eilt: Großinvestoren vor Einstieg in diesen Biotech Hot Stock - Massives Kaufsignal. Neuer 133% Biotech Hot Stock nach 3.296% mit BioNTech ($BNTX), 10.996% mit Pfizer ($PFE), 31.205% mit Amgen ($AMG) und 134.452% mit Biogen ($BIIB)
Eilt: Großinvestoren vor Einstieg in diesen Biotech Hot Stock - Massives Kaufsignal. 133% Biotech Aktientip nach 15.973%
17.01.24 08:02
London (www.aktiencheck.de, Anzeige)
![Time to buy these 3 healthcare companies that raised revenue guidance?: https://www.marketbeat.com/logos/articles/med_20240114165541_chart-exas2.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBLzRNYkE9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--6f6726c0f30bff53e31503bb77e9bbadba446018/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/med_20240114165541_chart-exas2.jpg?locale=de)
Time to buy these 3 healthcare companies that raised revenue guidance?
The new year brings a clean slate heading into the fourth-quarter earnings season. Companies can usually gauge if their previous forecasts were in line or need to be adjusted to warn or prepare
![Time to buy these 3 healthcare companies that raised revenue guidance?: https://www.marketbeat.com/logos/articles/med_20240114165541_chart-exas2.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBLzRNYkE9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--6f6726c0f30bff53e31503bb77e9bbadba446018/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/med_20240114165541_chart-exas2.jpg?locale=de)
Time to buy these 3 healthcare companies that raised revenue guidance?
The new year brings a clean slate heading into the fourth-quarter earnings season. Companies can usually gauge if their previous forecasts were in line or need to be adjusted to warn or prepare
![Affirm's pullback, short squeeze potential present a second chance: https://www.marketbeat.com/logos/articles/med_20240115101316_affirms-pullback-short-squeeze-potential-present-a.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBOUlNYkE9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--2b8d1bc4bc6f5595cb98fc17888c30a69ff1b6fa/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/med_20240115101316_affirms-pullback-short-squeeze-potential-present-a.jpg?locale=de)
Affirm's pullback, short squeeze potential present a second chance
Buy now, pay later (BNPL) leader Affirm Holdings Inc. (NASDAQ: AFRM) is having a 20% off sale that may be one of the best bargains in retail.
After riding a nine-week win streak to $52.48 on
![3 high-yielding, small banks to buy on the dip: https://www.marketbeat.com/logos/articles/med_20240115092448_chart-cade-1152023ver001.png](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBOUVNYkE9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--6a1447d0025904deaad1b79dfbcb94b640e5a292/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/med_20240115092448_chart-cade-1152023ver001.png?locale=de)
3 high-yielding, small banks to buy on the dip
Results from the big banks have the financial sector on the cusp of a correction. The news isn't bad, but strengths were priced into the market, setting it up for a healthy and needed reset. The
![Surgery Partners feeling no pinch from macroeconomic weakness: https://www.marketbeat.com/logos/articles/med_20240114164939_chart-sgry.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBNFlNYkE9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--e94a033fcc3a8fb5b9596fc70525f2a2abdd1c6f/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/med_20240114164939_chart-sgry.jpg?locale=de)
Surgery Partners feeling no pinch from macroeconomic weakness
Surgery Partners Inc. (NASDAQ: SGRY) is a leading healthcare services provider that owns and operates over 180 outpatient surgical centers in 31 states. Its integrated delivery model includes
![PayPal gearing up for a breakout despite shifting sentiment: https://www.marketbeat.com/logos/articles/med_20240115120327_paypal-gearing-up-for-a-breakout-despite-shifting.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBNHNNYkE9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--811839ee826b14090dccd7760f9fc8c0deb2a8f6/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/med_20240115120327_paypal-gearing-up-for-a-breakout-despite-shifting.jpg?locale=de)
PayPal gearing up for a breakout despite shifting sentiment
Few names outperformed PayPal Holdings Inc. (NASDAQ: PYPL) during the COVID-19 pandemic. Imagine a company that not only weathered the storm of the COVID-19 pandemic but thrived amidst the chaos,
![Bitcoin ETFs: A two-day ranking of top performers: https://www.marketbeat.com/logos/articles/med_20240115114740_bitcoin-etfs-a-two-day-ranking-of-top-performers.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBNE1NYkE9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--703b8b12f38e965c0be3451b89642b9a40bffb47/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/med_20240115114740_bitcoin-etfs-a-two-day-ranking-of-top-performers.jpg?locale=de)
Bitcoin ETFs: A two-day ranking of top performers
The recent approval and launch of eleven Bitcoin spot ETFs have added a thrilling chapter. Building up to the much-anticipated approval, the market was brimming with anticipation.
As the U.S.
![2 biotechs with promising weight-loss drugs coming: https://www.marketbeat.com/logos/articles/med_20240114165130_chart-vktx2.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBNFVNYkE9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--1beeff80657e84dcfd835627b1cd6ada42ca6d43/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/med_20240114165130_chart-vktx2.jpg?locale=de)
2 biotechs with promising weight-loss drugs coming
Clinical weight-loss medications have been making headlines. GLP-1 drugs like Novo Nordisk A/S (NYSE: NVO) owned Ozempic and Wegovy and Eli Lilly and Co. (NYSE: LLY) owned Mounjaro and Zepbound
![Power Plays: MSFT, NVDA, GOOGL, META dominate market moves: https://www.marketbeat.com/logos/articles/med_20240115072106_power-plays-msft-nvda-googl-meta-dominate-market-m.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBNG9NYkE9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--a6dffa83b3cf4743173fc72076adb98005fa372f/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/med_20240115072106_power-plays-msft-nvda-googl-meta-dominate-market-m.jpg?locale=de)
Power Plays: MSFT, NVDA, GOOGL, META dominate market moves
Last week, an interesting picture of triumph was painted in the stock market, with the technology sector taking the lead. Now, this may come as no surprise. The stars of the show were none other
![Affordable networking stocks to watch on the Juniper buyout: https://www.marketbeat.com/logos/articles/med_20240114163634_chart-infn.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBNGtNYkE9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--6a1e0330a3729ee8889756499d4b12705025c828/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/med_20240114163634_chart-infn.jpg?locale=de)
Affordable networking stocks to watch on the Juniper buyout
Hewlett Packard Enterprise Co. (NYSE: HPE) will acquire network communications equipment provider Juniper Networks Inc. (NASDAQ: JNPR) for around $14 billion or $40 per share. It sent shockwaves
![Power Plays: MSFT, NVDA, GOOGL, META dominate market moves: https://www.marketbeat.com/logos/articles/med_20240115072106_power-plays-msft-nvda-googl-meta-dominate-market-m.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBNG9NYkE9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--a6dffa83b3cf4743173fc72076adb98005fa372f/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/med_20240115072106_power-plays-msft-nvda-googl-meta-dominate-market-m.jpg?locale=de)
Power Plays: MSFT, NVDA, GOOGL, META dominate market moves
Last week, an interesting picture of triumph was painted in the stock market, with the technology sector taking the lead. Now, this may come as no surprise. The stars of the show were none other
![Power Plays: MSFT, NVDA, GOOGL, META dominate market moves: https://www.marketbeat.com/logos/articles/med_20240115072106_power-plays-msft-nvda-googl-meta-dominate-market-m.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBNG9NYkE9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--a6dffa83b3cf4743173fc72076adb98005fa372f/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/med_20240115072106_power-plays-msft-nvda-googl-meta-dominate-market-m.jpg?locale=de)
Power Plays: MSFT, NVDA, GOOGL, META dominate market moves
Last week, an interesting picture of triumph was painted in the stock market, with the technology sector taking the lead. Now, this may come as no surprise. The stars of the show were none other
![PayPal gearing up for a breakout despite shifting sentiment: https://www.marketbeat.com/logos/articles/med_20240115120327_paypal-gearing-up-for-a-breakout-despite-shifting.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBNHNNYkE9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--811839ee826b14090dccd7760f9fc8c0deb2a8f6/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/med_20240115120327_paypal-gearing-up-for-a-breakout-despite-shifting.jpg?locale=de)
PayPal gearing up for a breakout despite shifting sentiment
Few names outperformed PayPal Holdings Inc. (NASDAQ: PYPL) during the COVID-19 pandemic. Imagine a company that not only weathered the storm of the COVID-19 pandemic but thrived amidst the chaos,
![PayPal gearing up for a breakout despite shifting sentiment: https://www.marketbeat.com/logos/articles/med_20240115120327_paypal-gearing-up-for-a-breakout-despite-shifting.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBNHNNYkE9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--811839ee826b14090dccd7760f9fc8c0deb2a8f6/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/med_20240115120327_paypal-gearing-up-for-a-breakout-despite-shifting.jpg?locale=de)
PayPal gearing up for a breakout despite shifting sentiment
Few names outperformed PayPal Holdings Inc. (NASDAQ: PYPL) during the COVID-19 pandemic. Imagine a company that not only weathered the storm of the COVID-19 pandemic but thrived amidst the chaos,
![Eilt: Einstieg Institutioneller Investoren voraus - Massives Kaufsignal. Neuer 152% Biotech Aktientip nach 3.296% mit BioNTech ($BNTX), 10.996% mit Pfizer ($PFE), 31.205% mit Amgen ($AMG) und 134.452% mit Biogen ($BIIB): https://www.irw-press.at/prcom/images/messages/2024/73259/Aktiencheck160124.001.png](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBeTBNYkE9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--92398e49a70f10603abc888e676bca234f93922c/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/Aktiencheck160124.001.png?locale=de)
Eilt: Einstieg Institutioneller Investoren voraus - Massives Kaufsignal. Neuer 152% Biotech Aktientip nach 3.296% mit BioNTech ($BNTX), 10.996% mit Pfizer ($PFE), 31.205% mit Amgen ($AMG) und 134.452% mit Biogen ($BIIB)
Eilt: Einstieg Institutioneller Investoren voraus - Massives Kaufsignal. 152% Biotech Aktientip nach 134.452% mit Biogen
16.01.24
London (www.aktiencheck.de, Anzeige)
![Eilt: Einstieg Institutioneller Investoren voraus - Massives Kaufsignal. Neuer 152% Biotech Aktientip nach 3.296% mit BioNTech ($BNTX), 10.996% mit Pfizer ($PFE), 31.205% mit Amgen ($AMG) und 134.452% mit Biogen ($BIIB): https://www.irw-press.at/prcom/images/messages/2024/73259/Aktiencheck160124.001.png](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBeTBNYkE9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--92398e49a70f10603abc888e676bca234f93922c/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/Aktiencheck160124.001.png?locale=de)
Eilt: Einstieg Institutioneller Investoren voraus - Massives Kaufsignal. Neuer 152% Biotech Aktientip nach 3.296% mit BioNTech ($BNTX), 10.996% mit Pfizer ($PFE), 31.205% mit Amgen ($AMG) und 134.452% mit Biogen ($BIIB)
Eilt: Einstieg Institutioneller Investoren voraus - Massives Kaufsignal. 152% Biotech Aktientip nach 134.452% mit Biogen
16.01.24
London (www.aktiencheck.de, Anzeige)
![Eilt: Einstieg Institutioneller Investoren voraus - Massives Kaufsignal. Neuer 152% Biotech Aktientip nach 3.296% mit BioNTech ($BNTX), 10.996% mit Pfizer ($PFE), 31.205% mit Amgen ($AMG) und 134.452% mit Biogen ($BIIB): https://www.irw-press.at/prcom/images/messages/2024/73259/Aktiencheck160124.001.png](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBeTBNYkE9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--92398e49a70f10603abc888e676bca234f93922c/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/Aktiencheck160124.001.png?locale=de)
Eilt: Einstieg Institutioneller Investoren voraus - Massives Kaufsignal. Neuer 152% Biotech Aktientip nach 3.296% mit BioNTech ($BNTX), 10.996% mit Pfizer ($PFE), 31.205% mit Amgen ($AMG) und 134.452% mit Biogen ($BIIB)
Eilt: Einstieg Institutioneller Investoren voraus - Massives Kaufsignal. 152% Biotech Aktientip nach 134.452% mit Biogen
16.01.24
London (www.aktiencheck.de, Anzeige)
![MarketBeat ‘Stock of the Week’: Lucid a high risk EV penny stock: https://www.marketbeat.com/logos/articles/med_20240115085652_marketbeat-stock-of-the-week-lucid-a-high-risk-ev.png](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBL01MYkE9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--5ac75a64a1bdaa6b47d0a578c74ddcf15c7aa3f5/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/med_20240115085652_marketbeat-stock-of-the-week-lucid-a-high-risk-ev.png?locale=de)
MarketBeat ‘Stock of the Week’: Lucid a high risk EV penny stock
Since making a second run into the $50’s two years ago, Lucid Group Inc. (NASDAQ: LCID) has been a ‘clear’ loser.
On Friday, shares of the California-based luxury electric vehicle (EV) maker
![Lululemon stock falls on raised guidance: https://www.marketbeat.com/logos/articles/med_20240114163833_chart-lulu2.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBL0lMYkE9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--4a97182f53e31f8be99e581f37897ba3455f1ba1/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/med_20240114163833_chart-lulu2.jpg?locale=de)
Lululemon stock falls on raised guidance
Premium athleisure brand Lululemon Athletica Inc. (NASDAQ: LULU) entered the holiday shopping season with solid momentum, sending shares through its all-time highs and peaking at $516.39 on Dec
![Lululemon stock falls on raised guidance: https://www.marketbeat.com/logos/articles/med_20240114163833_chart-lulu2.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBL0lMYkE9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--4a97182f53e31f8be99e581f37897ba3455f1ba1/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/med_20240114163833_chart-lulu2.jpg?locale=de)
Lululemon stock falls on raised guidance
Premium athleisure brand Lululemon Athletica Inc. (NASDAQ: LULU) entered the holiday shopping season with solid momentum, sending shares through its all-time highs and peaking at $516.39 on Dec
![3 retailers to compound your wealth this cycle: https://www.marketbeat.com/logos/articles/med_20240115071736_3-retailers-to-compound-your-wealth-this-cycle.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBK1VMYkE9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--dc8ef2793c56c1ad85e714c26ec401e6246820b2/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/med_20240115071736_3-retailers-to-compound-your-wealth-this-cycle.jpg?locale=de)
3 retailers to compound your wealth this cycle
Today's market is the epitome of opportunity for those who know where to look. Considering that most market analysts suggest the stock market is overvalued today, by measures such as the Buffett
![Insidertrades.com uncovers the hottest insider activity from 2023: https://www.marketbeat.com/logos/articles/med_20240115074451_chart-wmt-1152024ver001.png](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBK01MYkE9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--0fa8550a09beea38e34b70b8e09e9df8fc55b0f7/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/med_20240115074451_chart-wmt-1152024ver001.png?locale=de)
Insidertrades.com uncovers the hottest insider activity from 2023
Insider activity can be a telling indicator of where a stock is heading, and the activity was hot in 2023. This is a look at the hottest insider trades tracked by Insidertrades.com. Within it are
![Insidertrades.com uncovers the hottest insider activity from 2023: https://www.marketbeat.com/logos/articles/med_20240115074451_chart-wmt-1152024ver001.png](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBK01MYkE9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--0fa8550a09beea38e34b70b8e09e9df8fc55b0f7/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/med_20240115074451_chart-wmt-1152024ver001.png?locale=de)
Insidertrades.com uncovers the hottest insider activity from 2023
Insider activity can be a telling indicator of where a stock is heading, and the activity was hot in 2023. This is a look at the hottest insider trades tracked by Insidertrades.com. Within it are